Everspin Earnings Call: MRAM Growth, Costs Rising

Everspin Technologies Inc ((MRAM)) has held its Q1 earnings call. Read on for the main highlights of the call.

Everspin Technologies’ latest earnings call struck a cautiously optimistic tone, with strong MRAM product momentum and expanding strategic partnerships offset by rising costs and near‑term profit volatility. Management emphasized resilient demand, improving margins, and a larger long‑term market, while acknowledging legal expenses, CapEx needs, and timing uncertainty around new defense‑related revenue.

Revenue Growth at High End of Guidance

Everspin delivered first‑quarter revenue of $14.9 million, landing near the high end of guidance and rising 14% year over year. Management framed this as evidence that core demand is healthy despite pockets of macro softness, underscoring that growth is coming from products rather than one‑time licensing deals.

MRAM Product Sales Drive the Top Line

MRAM product revenue reached $14.1 million, up a robust 28% from a year ago and 5% sequentially, powered by both Toggle and STT‑MRAM. This mix shift toward higher, recurring product sales is central to the bullish narrative, positioning the company as a more durable growth story rather than a contract‑driven business.

Non‑GAAP Profitability Strengthens Sharply

On a non‑GAAP basis, net income climbed to $2.6 million, or $0.11 per diluted share, versus just $0.4 million and $0.02 a year earlier. The roughly 450% year‑over‑year EPS jump, at the high end of guidance, signals better operating leverage even as the company invests in new platforms and capacity.

Gross Margins Stay Above 50% Target

GAAP gross margin improved to 52.7% from 51.4% a year ago, keeping Everspin comfortably above its 50% long‑term target. Management credited better factory utilization and yield improvements, suggesting that as volumes grow the business can maintain attractive structural profitability.

Major Contracts and Foundry Partnership Extend Reach

The company announced a new 2.5‑year, $40 million subcontract with a U.S. prime contractor, which should meaningfully expand defense‑related revenue once milestones are defined. Everspin also signed a 10‑year Foundry Services Agreement with Microchip to add an onshore MRAM manufacturing line, with first shipments expected in the second half of 2027.

UNISYST Roadmap Expands Addressable Market

Everspin unveiled its UNISYST MRAM family aimed at displacing high‑density NOR flash, targeting roughly $3 billion of additional market opportunity. The company is initially aiming to capture 5%–10% of that space, with high‑reliability 128Mb and 256Mb parts planned for the second half of 2026 and engineering samples by the fourth quarter of 2026.

Solid Balance Sheet Supports Investment

The balance sheet remains debt‑free, with $40.5 million in cash and cash equivalents at quarter end, giving Everspin flexibility to self‑fund growth. Management believes this liquidity is sufficient to execute the Microchip foundry ramp and advance the UNISYST product roadmap without resorting to borrowing.

End‑Market Diversification Gains Traction

Demand was broad‑based across industrial, transportation, and data‑center markets, helping to smooth sector‑specific volatility. The call highlighted inventory recovery in Japanese industrial automation, rail axle‑counter design wins in transportation, and ongoing IBM FCM and RAID design activity with top hyperscalers.

Licensing Revenue Drops Sharply

Licensing, royalty, patent, and other revenue fell to $0.8 million from $2.1 million a year ago, a drop of roughly 62%. Management tied the decline to fewer active licensing projects, reinforcing the shift toward a more sustainable, product‑centric revenue mix but also removing a historically high‑margin contributor.

Operating Expenses Climb on Legal and Talent

GAAP operating expenses rose to $10.6 million from $8.7 million, up about 22% year over year, driven mainly by litigation costs and higher compensation and professional fees. While some of this spending supports growth and innovation, the step‑up is weighing on near‑term operating margins and earnings.

Litigation Spend Pressures the Bottom Line

The company booked approximately $1.6 million of litigation expense in the quarter and signaled that spending is likely to stay in that range for at least a couple more quarters. These non‑operational costs are a key reason GAAP results trail non‑GAAP figures and remain an overhang on reported profitability.

Cash Flow Softens Despite Profit Gain

Cash and equivalents declined to $40.5 million from $44.5 million sequentially, while operating cash flow slid to $0.5 million from $2.6 million. Management attributed the weaker cash generation to litigation outlays and higher working capital needs, a trade‑off investors will watch closely as CapEx rises.

Timing Uncertainty Around New Subcontract Revenue

Although the new $40 million subcontract is expected to be a clear positive over the 2.5‑year term, management declined to provide near‑term revenue phasing or margin impact. This lack of detail introduces some short‑term forecasting uncertainty even as it enhances the multi‑year revenue visibility.

CapEx to Stay Elevated for Capacity Build‑Out

The company flagged above‑trend capital expenditures tied to its Chandler facility improvements and the forthcoming Microchip foundry ramp. Everspin expects meaningful CapEx over roughly the next two years, which could constrain near‑term free cash flow but is positioned as critical to supporting future MRAM growth.

Guidance Signals Near‑Term GAAP Loss

For the second quarter, excluding any benefit from the new subcontract, Everspin guided revenue to $15.5–$16.5 million with a GAAP net loss of $0.12 to $0.07 per share. On a non‑GAAP basis, management expects breakeven to $0.03 per share, highlighting the gap between underlying performance and reported results due to litigation and stock‑based compensation.

UNISYST Revenue Impact Pushed Beyond Midterm Horizon

While UNISYST materially enlarges Everspin’s long‑term market, its financial impact will be slow to appear given long development and qualification cycles. With engineering samples only in late 2026 and customer qualifications potentially adding another 18–24 months, management does not expect UNISYST to meaningfully influence its current three‑to‑five‑year revenue target.

Forward‑Looking Guidance and Multi‑Year Outlook

Management reiterated that the new $40 million subcontract should be materially accretive over its 2.5‑year life, even though specific milestone timing remains undisclosed. Looking further ahead, the company plans to wind down its existing $14.6 million defense contract by the first half of 2027, launch UNISYST samples in late 2026, and ship initial products from the Microchip line in the second half of 2027, framing a multi‑year growth runway.

Everspin’s earnings call painted a picture of a company trading near‑term earnings and cash‑flow volatility for a larger, more defensible franchise in MRAM. Robust product growth, solid margins, and strategic contracts support the bullish case, while litigation costs, heavier CapEx, and long lead times on new platforms temper expectations and keep execution firmly in focus for investors.